Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs.

Amplification of the gene encoding multidrug resistance-associated protein (MRP) and overexpression of its cognate mRNA have been detected in multidrug-resistant cell lines derived from several different tumor types. To establish whether or not the increase in MRP is responsible for drug resistance in these cell lines, we have transfected HeLa cells with MRP expression vectors. The transfectants display an increase in resistance to doxorubicin that is proportional to the levels of a M(r) 190,000, integral membrane protein recognized by anti-MRP antibodies. The transfectants are also resistant to vincristine and VP-16 but not to cisplatin. The results demonstrate that MRP overexpression confers a multidrug resistance phenotype similar to that formerly associated exclusively with elevated levels of P-glycoprotein.

[1]  S. Mirski,et al.  Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II. , 1991, Cancer research.

[2]  F. Baas,et al.  Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. , 1993, Cancer research.

[3]  I. Pastan,et al.  MDR1 gene expression in lung cancer. , 1989, Journal of the National Cancer Institute.

[4]  M. Pinkoski,et al.  Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. , 1992, British Journal of Cancer.

[5]  S. Cole.  The 1991 Merck Frosst Award. Multidrug resistance in small cell lung cancer. , 1992, Canadian journal of physiology and pharmacology.

[6]  A. M. van der Bliek,et al.  Sequence of mdr3 cDNA encoding a human P-glycoprotein. , 1988, Gene.

[7]  M. Slovak,et al.  Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein. , 1989, British Journal of Cancer.

[8]  D. Marquardt,et al.  Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells. , 1992, Cancer research.

[9]  P. Workman,et al.  Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines. , 1993, British Journal of Cancer.

[10]  M C Willingham,et al.  Immunocytochemical localization of P170 at the plasma membrane of multidrug-resistant human cells. , 1987, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[11]  J. Trent,et al.  Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. , 1988, Cancer research.

[12]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[13]  I. Roninson,et al.  Structure and expression of the human MDR (P-glycoprotein) gene family , 1989, Molecular and cellular biology.

[14]  J. Riordan,et al.  Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. , 1979, The Journal of biological chemistry.

[15]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[16]  M. Slovak,et al.  Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. , 1993, Cancer research.

[17]  J. Trent,et al.  Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. , 1991, British Journal of Cancer.

[18]  D. Housman,et al.  Isolation and expression of a complementary DNA that confers multidrug resistance , 1986, Nature.

[19]  M. Center,et al.  The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. , 1993, Cancer research.

[20]  P. Rabbitts,et al.  Non-P-glycoprotein-mediated multidrug resistance with reduced EGF receptor expression in a human large cell lung cancer cell line. , 1990, British Journal of Cancer.

[21]  T. Chung,et al.  Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Endicott,et al.  Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance , 1986, Nature.

[23]  F. Baas,et al.  The human mdr3 gene encodes a novel P‐glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver. , 1987, The EMBO journal.

[24]  C. Higgins,et al.  ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.